glp 1 drugs covered by medicare GLP-1 Drug Coverage New GLP-1 Medicare coverage |
Description
The cohort comprised patients over 20 years old who were newly treated with glucose-lowering drugs between 1 January 2013 and 31 December 2021, and followed until 30 September 2022
Obesity and Type 2 diabetes represent global health challenges, and there is an unmet need for long-lasting and effective pharmacotherapies
GLP-1 meds with no insurance, no hidden fees
For professionals in pharma, clinical research, and regulatory affairs, this space is evolving fastand full of opportunity
These statements have not been evaluated by the Food and Drug Administration
